Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation (Q39783688)

From Wikidata
Jump to navigation Jump to search
scientific article published on 8 November 2009
edit
Language Label Description Also known as
English
Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation
scientific article published on 8 November 2009

    Statements

    Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation (English)
    John C Araujo
    Nila U Parikh
    Michael W Starbuck
    Jerry T Thompson
    Christopher J Logothetis
    Bryant G Darnay

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit